Search research articles
Contact Us
Filters
Showing results (231-240 of 621) with videos related to
Page
of 63
Sort By:
Inflammatory Bowel Diseases
|
January 4, 2013
A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease
J P Wright, D P Jewell, R Modigliani, et al.
Clinical and Experimental Immunology
|
June 1, 1981
T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens
W S Selby, G Janossy, G Goldstein, et al.
Gut
|
August 1, 1992
Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes
P Hoang, B Crotty, H R Dalton, et al.
Lancet (London, England)
|
June 27, 2001
Crohn's disease: genetic susceptibility, bacteria, and innate immunity
D A Van Heel, D P McGovern, D P Jewell
Genes and Immunity
|
February 24, 2001
Is interleukin-6 important in inflammatory bowel disease?
K Koss, J Satsangi, K I Welsh, et al.
Gut
|
January 1, 1992
Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression
B Crotty, P Hoang, H R Dalton, et al.
Statistical Methods in Medical Research
|
August 3, 2018
On a general structure for hazard-based regression models: An application to population-based cancer research
Francisco J Rubio, Laurent Remontet, Nicholas P Jewell, et al.
The American Journal of the Medical Sciences
|
October 12, 2011
Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigation
David Y Graham, Nicholas P Jewell, Francis K L Chan
Clinical Science (London, England : 1979)
|
July 31, 1998
Genetics of inflammatory bowel disease
J Satsangi, M Parkes, D P Jewell, et al.
Mediators of Inflammation
|
December 5, 1998
The effect of interleukin-10 and transforming growth factor beta-1 on HLA-DR expression in colonic epithelial cells
M J Zimmerman, G R Radford-Smith, D P Jewell
Page
of 63
Search research articles
Search
Showing results (231-240 of 621) with videos related to
Sort By:
Page
of 63
Inflammatory Bowel Diseases
|
January 4, 2013
A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease
J P Wright, D P Jewell, R Modigliani, et al.
Clinical and Experimental Immunology
|
June 1, 1981
T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens
W S Selby, G Janossy, G Goldstein, et al.
Gut
|
August 1, 1992
Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes
P Hoang, B Crotty, H R Dalton, et al.
Lancet (London, England)
|
June 27, 2001
Crohn's disease: genetic susceptibility, bacteria, and innate immunity
D A Van Heel, D P McGovern, D P Jewell
Genes and Immunity
|
February 24, 2001
Is interleukin-6 important in inflammatory bowel disease?
K Koss, J Satsangi, K I Welsh, et al.
Gut
|
January 1, 1992
Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression
B Crotty, P Hoang, H R Dalton, et al.
Statistical Methods in Medical Research
|
August 3, 2018
On a general structure for hazard-based regression models: An application to population-based cancer research
Francisco J Rubio, Laurent Remontet, Nicholas P Jewell, et al.
The American Journal of the Medical Sciences
|
October 12, 2011
Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigation
David Y Graham, Nicholas P Jewell, Francis K L Chan
Clinical Science (London, England : 1979)
|
July 31, 1998
Genetics of inflammatory bowel disease
J Satsangi, M Parkes, D P Jewell, et al.
Mediators of Inflammation
|
December 5, 1998
The effect of interleukin-10 and transforming growth factor beta-1 on HLA-DR expression in colonic epithelial cells
M J Zimmerman, G R Radford-Smith, D P Jewell
Page
of 63